Risk of fatal and non-fatal cardiovascular events in men aged 25-44 in the city of Novosibirsk. Cohort study

Aim. To study the incidence and risk factors of cardiovascular events (CVEs) during an 8-year follow-up of a cohort of men aged 25-44 years (Novosibirsk).

Material and methods. The cohort study included 1415 people aged 37,33 [31,83; 41,92] years (Median, Me [interquartile range, Q25; Q75], of which 670 (47,3%) were men. Median follow-up period was 6,9 [5,8; 7,8] years. CVEs were identified using the "Registry of Acute Myocardial Infarction", fatal cases — from the "Medical Certificates of Cause of Death". The examination program included a questionnaire, anthropometry, biochemical studies. Statistical processing was carried out using SPSS (version 13.0).

Results. Thirteen CVEs were identified, of which 6 were fatal. Survival prognosis was more favorable in men without hypertension, with a heart rate (HR) <80 bpm. The risk of CVEs increased by 14% with an increase in fasting plasma glucose by 0,5 mmol/l, by 1,8 times with creatinine increase by 10 pmol/l (decreased by 29% with an increase in glomerular filtration rate by 5 ml/min /1,73 m²); 2 times with a heart rate increase by 10 bpm, regardless of other cardiometabolic risk factors.

Conclusion. Significant risk factors for fatal and non-fatal CVEs in men aged 25-44 years are hypertension, heart rate >80 bpm, increased fasting plasma glucose, creatinine levels (or decreased glomerular filtration rate).

1. Drapkina OM, Kontsevaya AV, Kalinina AM, et al. 2022 Prevention of chronic non-communicable diseases in the Russian Federation. National guidelines. Cardiovascular Therapy and Prevention. 2022;21(4):3235. (In Russ.) doi:10.15829/1728-8800-2022-3235.

2. Andersson С, Vasan RS. Epidemiology of cardiovascular disease in young individuals. Nature reviews. Cardiology. 2018;15(4):230-40. doi:10.1038/nrcardio.2017.154.

3. Dedov II, Mokrysheva NG, Mel'nichenko GA, et al. Obesity. Clinical guidelines. Consilium Medicum. 2021;23(4):311-25. (In Russ.) doi:10.26442/20751753.2021.4.20 0832.

4. Kobalava ZD, Konradi AO, Nedogoda SV, et al. Arterial hypertension in adults. Clinical guidelines 2020. Russian Journal of Cardiology. 2020;25(3):3786. (In Russ.) doi:10.15829/1560-4071-2020-3-3786.

5. Levin A, Stevens PE, Bilous RW, et al. Kidney disease: Improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney International Supplements. 2013;3(1):1-150. doi:10.1038/kisup.2012.73.

6. Gafarov VV, Gafarova AV. WHO programs "Acute Myocardial Infarction Register", MONICA: thirty years (1977-2006) of epidemiological studies of myocardial infarction in a high-risk population. Terapevticheskii arkhiv. 2011;83(1):38-45. (In Russ.)

7. Kouvari M, Panagiotakos DB, Chrysohoou C, et al. Attica Greecs Studies Investigators. Gender-specific, lifestyle-related factors and 10-year cardiovascular disease risk; the ATTICA and GREECS Cohort Studies. Curr Vasc Pharmacol. 2019;17(4):401-10. doi:10.2174/1570161116666180608121720.

8. Kumar AUA, Browne LD, Li X, et al. Temporal trends in hyper-uricaemia in the Irish health system from 2006-2014: A cohort study. PloS one. 2018;13(5):e0198197-e0198197. doi:10.1371/journal.pone.0198197.

9. Yureneva SV, Mychka VB, Ilyina LM, et al. Cardiovascular risk factors in women and the role of sex hormones. Cardiovascular Therapy and Prevention. 2011;10(4):128-35. (In Russ.) doi:10.15829/1728-8800-2011-4-128-135.

10. Zhang Y, Liu B, Zhao R, et al. The Influence of Sex on Cardiac Physiology and Cardiovascular Diseases. J Cardiovasc Transl Res. 2020;13(1):3-13. doi:10.1007/s12265-019-09898-x.

11. Cardiovascular prevention 2017. National guidelines. Russian Journal of Cardiology. 2018;(6):7-122. (In Russ.) doi:10.15829/1560-4071-2018-6-7-122.

12. Muromtseva GA, Kontsevaya AV, Konstantinov VV, et al. The prevalence of non-infectious diseases risk factors in russian population in 2012-2013 years. The results of ECVD-RF. Cardiovascular Therapy and Prevention. 2014;13(6):4-11. (In Russ.) doi: 10.15829/1728-8800-2014-64-11.

13. Filippov EV, Vorobyev AN, Dobrynina NV, et al. Adverse cardiovascular outcomes and their relationship with risk factors according to the prospective study MERIDIAN-RO. Russian Journal of Cardiology. 2019;(6):42-8. (In Russ.) doi:10.15829/1560-4071-2019-6-42-48.

14. Ivanova AYu, Dolgalev IV. Impact of Arterial Hypertension on the Formation of the Risk of Mortality. Results of a 27-Year Prospective Study. Kardiologiia. 2018;58(9):5-11. (In Russ.) doi:10.18087/cardio.2018.9.10168.

15. Yano Y, Stamler J, Garside DB, et al. Isolated systolic hypertension in young and middle-aged adults and 31-year risk for cardiovascular mortality: the Chicago Heart Association Detection Project in Industry study. J Am Coll Cardiol. 2015;65(4):327-35. doi:10.1016/j.jacc.2014.10.060.

16. Yano Y, Reis JP, Colangelo LA, et al. Association of Blood Pressure Classification in Young Adults Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline with Cardiovascular Events Later in Life. JAMA. 2018;320(17):1774-82. doi:10.1001/jama.2018.13551.

17. Lloyd-Jones DM, Lewis CE, Schreiner PJ, et al. The Coronary Artery Risk Development In Young Adults (CARDIA) Study: JACC Focus Seminar 8/8. J Am Coll Cardiol. 2021;78(3):260-277. doi:10.1016/j.jacc.2021.05.022.

18. Chen X, Barywani SB, Hansson PO, et al. Impact of changes in heart rate with age on all-cause death and cardiovascular events in 50-year-old men from the general population. Open Hear. 2019;6(1):e000856. doi:10.1136/openhrt-2018-000856.

19. Jensen MT, Suadicani P, Hein HO, et al. Elevated resting heart rate, physical fitness and all-cause mortality: a 16-year followup in the Copenhagen Male Study. Heart. 2013;99(12):882-7. doi:10.1136/heartjnl-2012-303375.

20. Tadic M, Cuspidi C, Grassi G. Heart rate as a predictor of cardiovascular risk. Eur J Clin Invest. 2018;48(3):e12892. doi:10.1111/eci.12892.

21. Raisi-Estabragh Z, Cooper J, Judge R, et al. Age, sex and disease-specific associations between resting heart rate and cardiovascular mortality in the UK BIOBANK. PLoS ONE. 2020;15(5):e0233898. doi:10,1371/journal.pone.0233898.

22. Shalnova SA, Kutsenko VA, Kapustina AV, et al. Associations of blood pressure and heart rate and their contribution to the development of cardiovascular complications and all-cause mortality in the russian population of 25-64 years. Rational Pharmacotherapy in Cardiology. 2020;16(5):759-69. (In Russ.) doi:10.20996/1819-6446-2020-10-02.

23. Kovalkova NA, Khudyakova AD, Shcherbakova LV, et al. Changes in glomerular filtration rate in young adults: population data. Siberian Scientific Medical Journal. 2020;40(2):91-8. (In Russ.) doi:10.15372/SSMJ20200213.

24. Ruyatkina LA, Yakhontov DA, Akhmerova EV. Factors affecting the vascular reactivity and glomerular filtration rate in young and middle-aged hypertensive patients depending on the presence of type 2 diabetes mellitus. Arterial Hypertension. 2015;21(3): 294-300. (In Russ.) doi:10.18705/1607-419X-2015-21-3-294-300.

25. Metelskaya VA, Zhatkina MV, Gavrilova NE, et al. Associations of circulating biomarkers with the presence and severity of coronary, carotid and femoral arterial atherosclerosis. Cardiovascular Therapy and Prevention. 2021;20(8):3098. (In Russ.) doi:10.15829/1728-8800-2021-3098.

26. Kamilova U, Alikulov IT. Kidney dysfunction evaluation in chronic heart failure patients. Cardiovascular Therapy and Prevention. 2014;13(2):51-4. (In Russ.) doi:10.15829/1728-8800-2014-2-51-54.

27. Dedov II, Shestakova MV, Vikulova OK, et al. Epidemiological characteristics of diabetes mellitus in the Russian Federation: clinical and statistical analysis according to the Federal diabetes register data of 01.01.2021. Diabetes mellitus. 2021;24(3):204-21. (In Russ.) doi:10.14341/DM12759.

28. Andes LJ, Cheng YJ, Rolka DB, et al. Prevalence of Prediabetes Among Adolescents and Young Adults in the United States, 2005-2016. JAMA Pediatr. 2020;174(2):e194498. doi:10.1001/jamapediatrics.2019.4498.

29. Kaneko H, Itoh H, Kiriyama H, et al. Fasting plasma glucose and subsequent cardiovascular disease among young adults: Analysis of a nationwide epidemiological database. Atherosclerosis. 2021;319:35-41. doi:10.1016/j.atherosclerosis.2020.12.024.